Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
M. Pereira Cervan, C. Stipanich, T. Silva Souza, S. Zahi Rached, L. M. Brasileiro Gomes, I. C. Vilela Soares Oshiro, C. Tanaka, C. Fu, C. R. Ribeiro de Carvalho (Sao Paulo, Brazil). Comparative study of clinical diagnostic criteria for ventilator-associated pneumonia. Eur Respir J 2010; 36: Suppl. 54, 4938

Member's Comments

No comment yet.

Related content which might interest you: Prospective comparative study on etiologic diagnosis of ventilator-associated pneumonia. Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients Year: 2018 Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity Source: Eur Respir J 2006; 28: Suppl. 50, 530s Year: 2006 New approaches to the aetiological diagnosis of VAP Source: Eur Respir Mon 2011; 53: 11-23 Year: 2011 Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2013; 42: 742-749 Year: 2013 I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas! Year: 2009 Community-acquired pneumonia (CAP): evaluation of severity criteria for hospitalization Source: Eur Respir J 2003; 22: Suppl. 45, 335s Year: 2003 Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study Source: ERJ Open Res, 4 (4) 00096-2018; 10.1183/23120541.00096-2018 Year: 2018 Adherence to guidelines and clinical stability in community-acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Clinical decision support system for diagnosing patients with community-acquired pneumonia Source: Annual Congress 2011 - Integrated care and telehealth in primary care Year: 2011 The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: Guideline 2018 Year: 2019 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018 Year: 2018 Performance indicators to evaluate the management of patients with ventilator-associated pneumonia: results from the IMPACT-HAP study group Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 Bacteriological diagnosis in hospitalized community-acquired pneumonia (HCAP): an eighteen-month study Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 Comparative clinical analysis of COVID-19 pneumonia and bacterial pneumonia Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 Validation of treatment failure criteria of nosocomial pneumonia in ICU Source: Annual Congress 2011 - Intensive care outcome Year: 2011 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Guideline 2017 Year: 2017 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017 Year: 2017